Cumberland Pharmaceuticals (CPIX) Prepaid Assets (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Prepaid Assets of $2.1 million for Q1 2026, down 5.31% on a YoY basis from $2.2 million in Q1 2025, and down 15.5% sequentially from $2.4 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Prepaid Assets (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Prepaid Assets data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 5.31% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 5.31% YoY), and the FY2025 full-year result was $2.4 million, down 12.25% from the prior year.
- Prepaid Assets eased to $2.1 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.7 million in Q3 2022 to a low of $1.4 million in Q3 2025.
- A 5-year average of $2.5 million and a median of $2.4 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 196.95% in 2022 and plunged 47.28% in 2023, its largest moves.
- Tracing CPIX's Prepaid Assets over 5 years: stood at $3.1 million in 2022, then decreased by 1.94% to $3.0 million in 2023, then dropped by 7.89% to $2.8 million in 2024, then decreased by 12.25% to $2.4 million in 2025, then retreated by 15.5% to $2.1 million in 2026.
- Business Quant data shows CPIX's Prepaid Assets at $2.1 million in Q1 2026, $2.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.07 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 2.79 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | 3.08 Mn |
| Sep 30, 2022 | 3.74 Mn |
| Jun 30, 2022 | 2.84 Mn |
| Mar 31, 2022 | 3.56 Mn |
| Dec 31, 2021 | 3.34 Mn |
| Sep 30, 2021 | 1.26 Mn |
| Jun 30, 2021 | 1.76 Mn |